Backed by extensive experience in the healthcare sector, the fund manager has successfully executed over 25 investments across North America and Europe. Specializing in growth-stage opportunities, their strategic approach emphasizes a data-driven methodology that focuses on innovative medical technologies and biopharmaceuticals. Notable exits include several high-profile acquisitions, underscoring their ability to identify and cultivate promising ventures. Their operator-first style fosters strong partnerships, enhancing portfolio company performance and maximizing returns for investors.